Board Members


Chairman of the Board

Cellene Hoogenkamp is an international business consultant /director with skills in executive coaching, business development, marketing, sales and communications. Hoogenkamp has over 25 years experience in both private and public sectors including pharmaceuticals, health, financial services, music and management consultancy. She has served as a senior executive and board director, and has broad cultural experience in various world regions.

Hoogenkamp holds an MBA in International Business from the University of Technology, Sydney, and a BSc from La Trobe University, Melbourne.


In the development of effective cancer treatments, Cure First is about being smart, specific and targeted, rather than being generic. Not one cancer is the same, so why should the treatment be?
— Cellene Hoogenkamp



Family Physician, Research Fellow, Harvard University, Division on Health Policy and Education

Dr. Jeffrey Lee serves as Secretary and Communications Consultant for Cure First.  He is a graduate of Stanford University and Harvard Medical School.  He has practiced family medicine in Seattle since 1986, and is currently the medical director of the Neighborcare Health Rainier Beach Medical Clinic.  He writes a monthly column for Seattle’s Child Magazine, and has authored a book on parenting and a novel for young adults.

In my 27 years as a physician, I’ve seen remarkably little progress in the fight against cancer. We’re still using the same toxic chemotherapies and destructive radiation that we were a quarter century ago, and people are still dying and suffering in the same heart-breaking ways. I believe Cure First has the potential to change all that. This could be a revolution in the way we treat cancer. It is long, long overdue.
— Dr. Jeff Lee


Sandi Everlove is the Chief Learning Officer at Washington STEM. In this role, Everlove leads efforts to generate and share knowledge of innovation in STEM teaching and learning. In addition to working with funded partners to document insights and lessons learned. Prior to joining Washington STEM, Everlove founded TeachFirst where she led the development of innovative multimedia and face-to-face tools and resources to support teacher learning. She is an award-winning high school chemistry teacher with Seattle Public Schools and received the Washington State Golden Apple Award in 1998.


Dr. Patrick W. Gray is Chief Scientific Officer of bioMmune Technologies Inc. He has spent 30 years in the biotechnology industry. His significant accomplishments include the first cloning of Hepatitis B surface antigen, multiple Interferon-alpha genes, Interferon-gamma, Lymphotoxin (TNF-beta), Bactericidal Permeability Increasing Protein, LPS Binding Protein, Platelet Activating Factor Acetylhydrolase, CCR5 (subsequently shown to be the HIV co-receptor), and Macrophage Derived Chemokine. He has over 40 US patents on 20 different technologies and more than 100 scientific publications. Dr. Gray received his Ph in chemistry from the University of Colorado and his BS in biology from the University of Oregon.

kare spratt profile photo.jpg



Dr. Spratt is a research scientist with extensive knowledge and experience in molecular biology, cellular biology and biochemistry. She investigates signal transduction pathways, tumor microenvironment, and cell-cell interactions with in vitro cell cultures and in vivo animal models.  Dr. Spratt has been a Staff Scientist and Postdoctoral Fellow at Fred Hutchinson Cancer Research Center.

Currently Dr. Spratt is Director of Pre-clinical Therapeutic Development at Center for Childhood Cancer, Seattle Children's Research Institute.


Pro bono counsel provided by Adkins Black LLP